Dr. Vicente Vérez, director of the Finlay Vaccine Institute (IFV), confirmed this Wednesday that his center is only waiting for the approval of the studies by the Center for the State Control of Medicines, Equipment and Medical Devices (CECMED), to start studies in around 300 children with the Soberana 02 and Soberana Plus vaccine candidates.